March 29, 2012 – Two-year follow-up data from the pivotal PLATINUM Workhorse trial comparing the safety and ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.
March 29, 2012 — In the second year of an ongoing trial, the Resolute zotarolimus-eluting stent (Medtronic) achieved a ...
March 27, 2012 — Biodegradable polymer drug-eluting stents (DES) provide better long-term safety and efficacy than ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
March 20, 2012 - MarBlue Medical announced the global product launch of its CE-marked drug-eluting balloon (DEB) Protege ...
April 15, 2012, will mark the 10th anniversary of the approval of the first drug-eluting stent (DES). Ten years ago, the ...
March 16, 2012 - Depression increases the risk of death in patients who have a coronary stent implanted. After seven ...
March 9, 2012 — Boston Scientific Corp. announced the launch of the Promus Element everolimus-eluting coronary stent sys ...
March 6, 2012 — In a development that brings advanced combination therapy treatment of peripheral artery disease (PAD) t ...
February 24, 2012 – The U.S. Food and Drug Administration (FDA) this week granted the first coronary stent indication ...
February 20, 2012 — Medtronic announced U.S. Food and Drug Administration (FDA) approval of the Resolute Integrity drug ...
February 6, 2012 — InspireMD Inc. announced positive clinical results for its MGuard stent from a controlled randomized ...
February 6, 2012 — A medical technology company commercializing the world's first and only self-apposing stent to treat ...
February 1, 2012 — Boston Scientific announced the first patient use and European market launch of the Promus Element ...
January 23, 2012 – Boston Scientific Corp. said the U.S. District Court for the District of New Jersey has found all the ...
January 9, 2012 – A registry that includes every patient in Sweden having percutaneous coronary intervention (PCI) found ...
March 29, 2012